Navigation Links
RIPE Pilot Study Suggests Resveratrol May Improve Cognitive Function In The Elderly
Date:11/27/2012

SAN DIEGO, Nov. 27, 2012 /PRNewswire/ -- Findings from the "Resveratrol for Improved Performance in Elders" (RIPE) trial were presented last week at the 65th Annual Scientific Meeting of The Gerontological Society of America, which was hosted at the San Diego Convention Center from November 14 – 18.  The conference offered more than 400 scientific sessions to over 4,000 leaders in the field of aging from around the world.

The RIPE pilot study, a double-blind, placebo-controlled trial conducted by researchers at the University of Florida in Gainesville, followed cognitively intact men and women who orally ingested Resveratrol (provided by Reserveage Organics) in either 300 mg/d or 1000 mg/d doses over a 90-day period. Cognitive assessments were made at baseline and at the end of the study (Day 90) using: Hopkins Verbal Learning Test (HVLT), Digits Forward and Backward (DFB), Controlled Oral Word Association (COWA), Trail Making Tests (TMT: A & B), Digit Symbol Copy number (DSCN), and Digit Symbol Substitution Test (DSST).

Compared to placebo, Resveratrol supplementation taken in the 1000 mg/d dose improved psychomotor (processing) speed and significantly increased hippocampal activation (increased blood flow to the brain). Resveratrol, a natural polyphenolic compound present in various dietary sources including peanuts, grapes, red wine, and Japanese knotweed, has demonstrated a wide range of physiological benefits in humans.

"Our findings are supportive of a short-term course of Resveratrol supplementation for enhancing psychomotor speed and increasing hippocampal activation. We also observed exciting trends suggesting memory was improved," said lead researcher Steve Anton, Ph.D.,** from the Dept. of Aging and Geriatric Research and Institute on Aging at the University of Florida. "The results are very promising and show that Resveratrol may have a predictable positive impact on cognitive function in older adults."

The RIPE study, summarized in a poster presentation was supported by the McKnight Brain Research Foundation at the University of Florida; the NIH/NIA Claude D. Pepper Center; and Thomas H. Maren Foundation. Reserveage Organics, which provided Resveratrol supplements for the study, is based in Gainesville, Florida.  
**Steve Anton, Ph.D. periodically serves as a consultant for Reserveage Organics.


'/>"/>
SOURCE Reserveage Organics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bluechiip Receives First Sales Order from ATCC after Completion of Successful Pilot Trial
2. In Pilot Study, a Peptide Controls Blood Sugar in People with Congenital Hyperinsulinism
3. Ocular Therapeutix Commences Pilot Phase II Travoprost Punctum Plug Study for the Treatment of Glaucoma
4. Systagenix begins pilot with ToolsGroup to optimise inventory levels
5. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
6. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
7. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
8. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
9. Shingles Vaccine is Safe, According to New Study
10. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
11. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... AVIV, Israel , May 19, 2016 ... or the "Company"), an emerging global ophthalmic company focused ... product candidates which address ophthalmic conditions, announced today that ... Italy ) for the manufacturing, distribution, ... product for the treatment of dry eye syndrome (DES) ...
(Date:5/19/2016)... May 19, 2016 A new ... Heart Failure (CHF) Treatment Devices Market - Opportunities and ... devices market would reach $14.8 billion by 2022, at ... cardioverter-defibrillator (ICDs) segment is expected to dominate the world ... North America is projected to continue ...
(Date:5/19/2016)... 2016 A new report ... Robotics and Computer-Assisted Surgery Market - Opportunities and ... robotics and computer-assisted surgery market would reach $20.5 ... the highest revenue-generating segment, accounting for nearly half ... expected to maintain its dominance throughout the forecast ...
Breaking Medicine Technology:
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... ... care retirement community, dedicated its new $11.5 million, 64-room assisted living center. After ... ceremony and ribbon cutting. , The new building provides the latest in ...
(Date:5/23/2016)... ... , ... According to an article published May 12th on the Medical Daily, as ... hygiene. The article points out that, as long as patients are brushing as they should ... frayed. Of course, these worn-out bristles won’t clean teeth and gum tissue as effectively, so ...
(Date:5/23/2016)... CA (PRWEB) , ... May 23, 2016 , ... Researchers ... is so routine. A fresh look at this technique may yield big benefits. ... reproducibility of experiments in a cell culture laboratory—and lessen the risk of ...
(Date:5/23/2016)... ... ... NYDNRehab, a New York City-based physical therapy clinic , is introducing ... type of technology, which was developed by world-renowned researcher Dr. Christopher Powers of University ... With over 10 million sport injuries per year in the United States, ...
(Date:5/23/2016)... ... May 23, 2016 , ... ComplianceOnline, the leading governance, risk and compliance advisory ... on September 15 and 16, 2016 in San Diego, CA. The two day ... will be one of the largest gatherings of medical device companies, suppliers, professionals and ...
Breaking Medicine News(10 mins):